X-ray preactivated reversible persistent luminescence enables photodynamic immunotherapy of deep tumors
Topatana Win, Sun Yuchao, Xie Tianao, Zhu Yiyuan, Yang Taorui, Shen Ruijing, Ran Peng, Li Chengao, Chen Jiadong, Shen Xuqiu, Lu Ziyi, Han Yina, Shan Yukai, Li Shijie, Chen Tianen, Cai Xiujun, Deng Re
Journal:Nature Communications
IF:18.1
DOI:10.1038/s41467-026-71028-4
PMID:41865031
Published:2026-03-21
research field:肿瘤学光动力治疗生物医学工程免疫治疗纳米医学
Abstract
Persistent luminescence is a promising approach for photodynamic therapy (PDT) in deep-seated tumors, as it provides sustained light within tissues, eliminating the need for continuous external illumination. However, the uncontrollability of light within the body complicates precise spatiotemporal regulation. In this study, we report X-ray preactivated elimusertib-loaded tumor-targeted photodynamic nanoparticles (ETPNs), featuring reversible “on-off” afterglow properties. The excellent afterglow properties of X-ray-activated porous NaYF 4 :Er@NaGdF 4 persistent luminescence nanoparticles enable the continuous activation of chlorin e6 (Ce6) to generate reactive oxygen species (ROS), leading to DNA damage. The integration of elimusertib potentiates ROS-induced DNA damage and activates the cGAS-STING pathway, thereby enhancing immuno-photodynamic therapeutic efficacy. All in vivo experiments were conducted using female mice. Our findings highlight the potential of ETPNs to advance the therapeutic landscape for deep-seated tumors, offering a robust and controllable platform for combined immuno-photodynamic therapy.
本文使用的Yeasen产品


